ORAGENICS INC (OGEN) Form 8-K — Jul 6, 2026
$OGENForm 8-KItems 1.01, 5.02, 5.07, 9.01Filed Jul 6, 2026, 4:05 PM ET0001493152-26-032155Original filing
Oragenics appointed John Spencer as Chief Financial Officer effective July 1, 2026, promoting him from his role as Senior Controller. Spencer's background includes previous experience as Vice President of Finance at Trxade Health, Inc. and a tenure at PricewaterhouseCoopers LLP. The Company entered into an employment agreement with Spencer providing a base salary of $200,000 and an option award valued at $25,000.
Key figures
- Base Salary
- 200000
- Option Award
- 25000
- Reverse split vote for
- 1239961
- Reverse split ratio range
- 1:2 to 1:50
- Reverse split vote abstain
- 27366
- Reverse split vote against
- 836159
Price after filing
1 day: -1.3%7 days: -1.7%30 days: -5.2%
Close on the filing date to close N calendar days later (from $0.58). Historical, not a forecast.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.